WeVote
Log In

Bill

Bill

HB 50

Relating to informed consent for certain screening tests.

89th Legislature (2025) Introduced by Alma Allen and 66 co-sponsors

HB 50 mandates informed consent disclosures before specific screening tests in Texas, requiring healthcare providers to inform patients of test details, risks, and benefits before administration.

Left pending in committee
#blood&medicaltests(s0470) #health&humanservicescommission(v0177) #healthcareproviders(i0387) #health--aids(i0382) #informedconsent(s0057)
0
WeVote Research Nonpartisan
Bill Summary · HB 50

Legislative bill overview

HB 50 requires healthcare providers to obtain informed consent from patients before administering certain screening tests. The bill specifies what information must be disclosed to patients before these tests are performed, establishing new requirements for medical practitioners in Texas.

Why is this important

Informed consent protections affect healthcare access and patient autonomy. This legislation directly impacts how medical professionals conduct screenings and what conversations must occur before testing, potentially influencing screening rates and healthcare decision-making across the state.

Potential points of contention

  • Definition ambiguity: The bill's designation of "certain screening tests" may be unclear, creating uncertainty about which tests require the enhanced consent process and potentially burdening medical practices with compliance questions
  • Healthcare provider burden: New documentation and disclosure requirements could increase administrative costs and time spent per patient visit, affecting healthcare delivery efficiency
  • Balance with public health: Stricter consent requirements might reduce screening participation rates for important preventive tests, potentially conflicting with public health goals of early disease detection

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.